RPg Family Wealth Advisory’s PRA Health Sciences, Inc. PRAH Stock Holding History

RPg Family Wealth Advisory’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1.59M	Sell	12,696 -225	-2%	-$25.2K	0.75%	46
2020 Q3	$1.31M	Sell	12,921 -588	-4%	-$60K	0.69%	50
2020 Q2	$1.31M	Sell	13,509 -462	-3%	-$43K	0.8%	47
2020 Q1	$1.16M	Sell	13,971 -23	-0.2%	-$2.24K	0.9%	38
2019 Q4	$1.56M	Sell	13,994 -654	-4%	-$67.3K	0.89%	38
2019 Q3	$1.45M	Sell	14,648 -1,065	-7%	-$106K	0.88%	34
2019 Q2	$1.56M	Sell	15,713 -939	-6%	-$89.6K	0.92%	34
2019 Q1	$1.84M	Buy	16,652 +572	+4%	+$59.8K	1.08%	31
2018 Q4	$1.48M	Sell	16,080 -1,463	-8%	-$148K	1.44%	23
2018 Q3	$1.93M	Sell	17,543 -145	-0.8%	-$15.1K	1.46%	27
2018 Q2	$1.65M	Sell	17,688 -663	-4%	-$57.1K	1.28%	29
2018 Q1	$1.52M	Buy	18,351 +39	+0.2%	+$3.46K	1.25%	28
2017 Q4	$1.67M	Buy	+18,312	New	+$1.52M	1.41%	24

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

RPg Family Wealth Advisory's PRAH Position: Q4 2020 in Review

RPg Family Wealth Advisory reduced its PRA Health Sciences, Inc. (PRAH) stake by 1.7% in Q4 2020, selling an estimated $25.2K and leaving 12,696 shares worth $1.59M. The position accounts for 0.75% of the portfolio, ranked #46.

RPg Family Wealth Advisory first reported a position in PRAH in Q4 2017 and has held it in 13 quarters since. The position peaked at $1.93M in Q3 2018. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

RPg Family Wealth Advisory held 12,696 shares of PRA Health Sciences, Inc. worth $1.59M as of Q4 2020.
RPg Family Wealth Advisory sold 225 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $25.2K.
PRA Health Sciences, Inc. made up 0.75% of RPg Family Wealth Advisory's portfolio in Q4 2020, its #46 holding.
RPg Family Wealth Advisory first reported a position in PRA Health Sciences, Inc. in Q4 2017 and has held it in 13 quarters since.
RPg Family Wealth Advisory's PRA Health Sciences, Inc. position peaked at $1.93M in Q3 2018.
289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on RPg Family Wealth Advisory's 13F filing for Q4 2020, filed 16 Feb 2021.